Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals. She appears on CNBC's Business Day programming, contributes to CNBC.com and is based at the network's global headquarters in Englewood Cliffs, N.J.
Prior to joining CNBC, she led coverage of the biotechnology industry for Bloomberg News. She broke news on proxy fights, mergers and acquisitions, and drug development, and wrote features that illuminate how science and business meet. She also contributed to Bloomberg Television and Bloomberg Businessweek.
She holds a master's degree in journalism from Northwestern University and a bachelor's degree in English and music from Wellesley College.
Follow her on Twitter @megtirrell.
Two drugs are approaching FDA review of Duchenne muscular dystrophy, a rare genetic disease that puts kids in wheelchairs by their teens and is generally fatal by age 30. The mother of two boys with these disease speaks on the importance of this moment.